JPRN-jRCTs031180328已完成未知
Comparison of intravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.
Kitano Shigehiko0 个研究点目标入组 38 人开始时间: 2019年3月18日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
In diabetic macular edema, no significant effect of improving retinal thickness and visual acuity was confirmed in the combination group compared to the single group. In addition, there was no significant difference between the two groups in the number of doses of ranibizumab and the average dosing interval.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •HbA1c under 10 %
- •CRT over 300 micrometer
- •BCVA over 0.1
- •Written informed consent
排除标准
- •Posttreatment for diabetic macular edema within 3 months
研究者
相似试验
已完成
不适用
The effect and the safety with0.1% bromfenac sodium hydrate ophthalmic solution and 0.1% betamethasone sodium phosphate ophthalmic solution in patients with diabetic macular edema.JPRN-jRCTs031180308Kitano Shigehiko20
已完成
不适用
Evaluation of Ranibizumab for diabetes macular edemadiabetes macular edemaJPRN-UMIN000001984Yamagata University faculty of Medecine,department of ophthalmology10
已完成
4 期
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular EdemaRetinal DiseasesNCT02646670Instituto de Olhos de Goiania20
进行中（未招募）
1 期
Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) TrialEUCTR2017-003243-37-GBMUST Coordinating Centre, John Hopkins Bloomberg School of Public Health240
已完成
4 期
Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment EvaluationDiabetic RetinopathyNCT01223612Moorfields Eye Hospital NHS Foundation Trust37